Background illustration for clinical trials search

Paid Clinical Trials Virginia

Discover 1,859 paid clinical trials in Virginia. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter
1
Active & Responsive

Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors

for
Prostate Cancer Castration-resistant Prostate Cancer,
Location: East Brunswick NJ, Fairfax VA, Grand Rapids MI,
Sponsor: MBrace Therapeutics

Sex: All

Age: 18+

Code: NCT07145255

Phase1, Phase2, Recruiting
Active & Responsive

Impact of Food Assistance on Treatment Adherence and Clinical Outcomes in Food-Insecure Cancer Pts

for
Treatment Adherence
Location: Richmond VA
Sponsor: Virginia Commonwealth University

Sex: All

Age: 18+

Code: NCT07706192

Recruiting
Active & Responsive

Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer

for
Extensive Stage Lung Small Cell Carcinoma,
Location: North Haven CT, New Haven CT, Trumbull CT, New York NY,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06287775

Phase1, Phase2, Recruiting
Active & Responsive

A Study to Learn About the Safety and Effects of the Study Drug PRX-102 in Children and Adolescents With Fabry Disease

for
Fabry Disease
Location: Fairfax VA, Atlanta GA, Cincinnati OH, Iowa City IA,
Sponsor: Chiesi Farmaceutici S.p.A.

Sex: All

Age: 2 - 17

Code: NCT06328608

Phase2, Phase3, Recruiting
Active & Responsive

A Study of NEOK001, a B7-H3 and ROR1 Targeting Bispecific ADC in Participants With Select Solid Tumors

for
Locally Advanced (Unresectable) or Metastatic Solid Tumors
Location: New York NY, Fairfax VA, Nashville TN, Houston TX,
Sponsor: NEOK Bio, Inc.

Sex: All

Age: 18+

Code: NCT07612176

Phase1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

ASHBY: Accelerated Super-Hypofractionated Breast Brachytherapy

for
Breast Cancer
Location: Richmond VA
Sponsor: Virginia Commonwealth University

Sex: Female

Age: 45 - 70+

Code: NCT06185205

Phase2, Recruiting
Active & Responsive

A Study of IDE849 in Patients With DLL3 Expressing Tumors Including Small Cell Lung Cancer

for
Small-cell Lung Cancer, Neuroendocrine Carcinomas,
Location: New York NY, Philadelphia PA, Fairfax VA, Orlando FL,
Sponsor: IDEAYA Biosciences

Sex: All

Age: 18+

Code: NCT07174583

Phase1, Phase2, Recruiting
Active & Responsive

A 2-part Phase 1/2 Open-label Trial on ODM-212

for
Mesothelioma, Pancreatic Cancer,
Location: Fairfax VA, Irving TX
Sponsor: Orion Corporation, Orion Pharma

Sex: All

Age: 18+

Code: NCT07563738

Phase1, Phase2, Recruiting
Active & Responsive

CONTIGO - A Narrative Intervention to Enhance Genetic Counseling and Testing

for
Hereditary Breast and Ovarian Cancer
Location: Washington D.C. DC, Richmond VA
Sponsor: Georgetown University

Sex: Female

Age: 18+

Code: NCT05130606

Recruiting
Active & Responsive

A Gaucher Disease Gene Therapy Trial With FLT201

for
Gaucher Disease Type 1
Location: New York NY, Montreal, Philadelphia PA, Fairfax VA,
Sponsor: Spur Therapeutics

Sex: All

Age: 18+

Code: NCT07223944

Phase3, Recruiting
Active & Responsive

Efficacy, Safety, and Tolerability of Zeleciment Basivarsen (DYNE-101) in Participants With Myotonic Dystrophy Type 1

for
Myotonic Dystrophy Type 1 (DM1), DM1, Myotonic Dystrophy,
Location: Richmond VA, Atlanta GA, Hillsborough NC,
Sponsor: Dyne Therapeutics

Sex: All

Age: 16+

Code: NCT07486934

Phase3, Recruiting
Active & Responsive

A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)

for
Macular Degeneration, Age-Related Macular Degeneration,
Location: Hauppauge NY, Cherry Hill NJ, Bethlehem PA,
Sponsor: EyeBiotech Ltd.

Sex: All

Age: 50+

Code: NCT07440225

Phase2, Phase3, Recruiting
Active & Responsive

Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors

for
Solid Tumor Malignancies, Colorectal Carcinoma,
Location: Philadelphia PA, Fairfax VA, Orlando FL,
Sponsor: Tasca Therapeutics

Sex: All

Age: 18+

Code: NCT07030257

Phase1, Phase2, Recruiting
Active & Responsive

A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors

for
Solid Tumor, Non-Small-Cell Lung Cancer,
Location: New York NY, Hackensack NJ, Fairfax VA, Buffalo NY,
Sponsor: Astellas Pharma Inc

Sex: All

Age: 18+

Code: NCT07094204

Phase1, Recruiting
Active & Responsive

Treatment of Inflammatory Myelitis and Optic Neuritis With Early vs Rescue Plasma Exchange (TIMELY-PLEX)

for
Optic Neuritis, Myelitis, Myelitis, Transverse
Location: Boston MA, North Haven CT, New York NY, Baltimore MD,
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT07100990

Phase3, Recruiting
Active & Responsive

A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy

for
Kidney Disease
Location: East Providence RI, Philadelphia PA, Media PA,
Sponsor: Takeda

Sex: All

Age: 18+

Code: NCT06963827

Phase3, Recruiting
Active & Responsive

A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas

for
Triple Negative Breast Cancer, HER2-negative Breast Cancer,
Location: Fairfax VA, Orlando FL, Huntersville NC, Sarasota FL,
Sponsor: Dren Bio

Sex: All

Age: 18+

Code: NCT06999187

Phase1, Recruiting
Active & Responsive

Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD

for
Atherosclerotic Cardiovascular Disease (ASCVD)
Location: Summit NJ, Bowie MD, Ft. Washington MD, Falls Church VA,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT06813911

Phase3, Recruiting
Active & Responsive

A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer

for
Prostate Cancer,
Location: Myrtle Beach SC, Charlottesville VA, Tampa FL,
Sponsor: Astellas Pharma Global Development, Inc.

Sex: Male

Age: 18+

Code: NCT07005154

Phase2, Recruiting
Active & Responsive

SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)

for
Glioma, Astrocytoma, Grade IV, IDH1-mutant Glioma,
Location: Boston MA, New Haven CT, New York NY, New Brunswick NJ,
Sponsor: Nuvation Bio Inc.

Sex: All

Age: 18+

Code: NCT05303519

Phase3, Recruiting

Popular cities in Virginia

ChesapeakeVirginia BeachRichmondNorfolk